Sign in

CIK 0000946644

  • Non-accelerated filer
  • Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
520845822
Phone
+1 352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
  1. 4 Open-market buy Chief Science/Medical Officer bought 7,937 shares at $0.63 ($5,000)
  2. 4 Open-market buy CFO bought 15,873 shares at $0.63 ($10,000)
  3. 4 Open-market buy CEO, President bought 72,464 shares at $0.69 ($50,000)
  4. 4 Open-market buy CEO, President bought 200,000 shares at $0.50 ($100,000)
  5. 4 Open-market buy Director bought 15,750 shares at $2.21 ($34,808)
  6. 3 Insider Initial Statement of Ownership
  7. 4/A Open-market buy Sr VP of Operations bought 8,014 shares at $0.46 ($3,686)
  8. 4 Open-market buy Chief Science/Medical Officer bought 9,892 shares at $0.46 ($4,550)
  9. 4 Open-market buy Sr VP of Operations bought 8,014 shares at $0.46 ($3,686)
  10. 4 Open-market buy CFO bought 6,981 shares at $0.46 ($3,211)
  11. 4 Open-market buy CEO, President bought 68,493 shares at $0.73 ($50,000)
  12. 4 Open-market buy CEO,President bought 10,000 shares at $1.00 ($10,000)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 16 of 31 · 616 filings